Letters

Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.

Latest

AHA's feedback on the Department of Health and Human Services’ Office of the Assistant Secretary for Planning and Evaluation’s request for information on ensuring patient access and effective drug enforcement regarding controlled substances.
AHA's comments on the Department of Health and Human Services’ proposed rule to modify the current regulations implementing Section 1557 of the Affordable Care Act and certain other provisions of law.
AHA comments on the Centers for Medicare & Medicaid Services’ request for information on reducing administrative burden.
AHA letter to Senator Steve Daines expressing support for the Competitive Health Insurance Reform Act of 2019 (S. 350).
AHA letter to Suzan DelBene regarding her work on the Improving Seniors’ Timely Access to Care Act of 2019 (H.R. 3107), bipartisan legislation that would establish requirements for the use of prior authorization under Medicare Advantage plans.
AHA letter to Congressman Peter DeFazio expressing support for the Competitive Health Insurance Reform Act of 2019 (H.R. 1418).
AHA, AONL letter to Senator Rand Paul expressing support for the Backlog Elimination, Legal Immigration, and Employment Visa Enhancement Act, S. 2091.
The AHA, AAMC and FAH agree with the Committee’s goal of reducing the price of drugs, and applaud many of the steps outlined in the description of the Chairman’s Mark of the Prescription Drug
AHA comments on provisions of the Reauthorizing and Extending America’s Community Health (REACH) Act.
AHA comments on the Centers for Medicare & Medicaid Services’ proposed guidance for hospital co-location with other hospitals or health care facilities.